Wales PW, de Silva N, Kim J, Lecce L, To T, Moore A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg. 2004;39(5):690–5.
Zafirovska M, Zafirovski A, Kozjek NR. Current insights regarding intestinal failure-associated liver disease (IFALD): a narrative review. Nutrients. 2023. https://doi.org/10.3390/nu15143169.
Article PubMed PubMed Central Google Scholar
Raman M, Almutairdi A, Mulesa L, Alberda C, Beattie C, Gramlich L. Parenteral nutrition and lipids. Nutrients. 2017. https://doi.org/10.3390/nu9040388.
Article PubMed PubMed Central Google Scholar
Gura KM. The power of networking and lessons learned from Omegaven. J Pediatr Pharmacol Ther. 2020;25(8):663–74.
PubMed PubMed Central Google Scholar
Gura KM, Premkumar MH, Calkins KL, Puder M. Fish oil emulsion reduces liver injury and liver transplantation in children with intestinal failure-associated liver disease: a multicenter integrated study. J Pediatr. 2021;230(46–54): e2.
Belza C, Thompson R, Somers GR, et al. Persistence of hepatic fibrosis in pediatric intestinal failure patients treated with intravenous fish oil lipid emulsion. J Pediatr Surg. 2017;52(5):795–801.
Lacaille F, Gupte G, Colomb V, et al. Intestinal failure-associated liver disease: a position paper of the ESPGHAN working group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2015;60(2):272–83.
Article CAS PubMed Google Scholar
Vanek VW, Seidner DL, Allen P, et al. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012;27(2):150–92.
Park KT, Nespor C, Kerner J. The use of Omegaven in treating parenteral nutrition-associated liver disease. J Perinatol. 2011;31(Suppl 1):S57-60.
Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48(2):209–15.
Article CAS PubMed Google Scholar
Wake K. Hepatic stellate cells: Three-dimensional structure, localization, heterogeneity and development. Proc Jpn Acad Ser B Phys Biol Sci. 2006;82(4):155–64.
Article CAS PubMed PubMed Central Google Scholar
Senoo H, Hata R-I, Nagai Y, Wake K. Stellate cells (vitamin A-storing cells) are the primary site of collagen synthesis in non-parenchymal cells in the liver. Biomed Res. 1984;5(6):451–8.
Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A. 1985;82(24):8681–5.
Article CAS PubMed PubMed Central Google Scholar
Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.
Friedman SL. Transcriptional regulation of stellate cell activation. J Gastroenterol Hepatol. 2006;21(Suppl 3):S79-83.
Hu S, Bae M, Park YK, Lee JY. N-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells. J Nutr Biochem. 2020;85: 108452.
Article CAS PubMed Google Scholar
Shan C, Wang R, Wang S, et al. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways. Exp Physiol. 2021;106(4):983–93.
Article CAS PubMed Google Scholar
Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54(1):142–51.
Article CAS PubMed PubMed Central Google Scholar
da Silva CM, Caetano FH, Pereira FDC, Morales MAM, Sakane KK, Moraes KCM. Cellular and molecular effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts on retinoid metabolism in the human hepatic stellate cell LX-2. BMC Complement Altern Med. 2019;19(1): 222.
Article PubMed PubMed Central Google Scholar
Haaker MW, Vaandrager AB, Helms JB. Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels. Biochimica et Biophysica Acta (BBA). 2020;1865(6): 158674.
Moriwaki H, Blaner WS, Piantedosi R, Goodman DS. Effects of dietary retinoid and triglyceride on the lipid composition of rat liver stellate cells and stellate cell lipid droplets. J Lipid Res. 1988;29(11):1523–34.
Article CAS PubMed Google Scholar
Yamada M, Blaner WS, Soprano DR, Dixon JL, Kjeldbye HM, Goodman DS. Biochemical characteristics of isolated rat liver stellate cells. Hepatology. 1987;7(6):1224–9.
Article CAS PubMed Google Scholar
Testerink N, Ajat M, Houweling M, et al. Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of hepatic stellate cells during activation. PLoS ONE. 2012;7(4): e34945.
Article CAS PubMed PubMed Central Google Scholar
Shmarakov IO, Jiang H, Liu J, Fernandez EJ, Blaner WS. Hepatic stellate cell activation: a source for bioactive lipids. Biochimica et Biophysica Acta (BBA). 2019;1864(5):629–42.
Hernández-Gea V, Friedman SL. Autophagy fuels tissue fibrogenesis. Autophagy. 2012;8(5):849–50.
Article PubMed PubMed Central Google Scholar
Tsukamoto H. Fat paradox in liver disease. Keio J Med. 2005;54(4):190–2.
Article CAS PubMed Google Scholar
Carpentier YA, Deckelbaum RJ. In vivo handling and metabolism of lipid emulsions. World Rev Nutr Diet. 2015;112:57–62.
Oliveira FL, Rumsey SC, Schlotzer E, Hansen I, Carpentier YA, Deckelbaum RJ. Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr. 1997;21(4):224–9.
Article CAS PubMed Google Scholar
Carpentier YA, Dupont I, Portois L, Malaisse WJ. Preclinical investigations of a medium-chain triglyceride:fish oil emulsion III. experiments in cultured endothelial cells. Int J Mol Med. 2006;18(6):1177–85.
Rossi I, Marodin G, Lupo MG, et al. Gene silencing of Angiopoietin-like 3 (ANGPTL3) induced de novo lipogenesis and lipid accumulation in Huh7 cell line. Int J Mol Sci. 2024;25(7): 3708.
Article CAS PubMed PubMed Central Google Scholar
Teratani T, Tomita K, Furuhashi H, et al. Lipoprotein lipase up-regulation in hepatic stellate cells exacerbates liver fibrosis in nonalcoholic steatohepatitis in mice. Hepatol Commun. 2019;3(8):1098–112.
Article CAS PubMed PubMed Central Google Scholar
Jarc E, Petan T. A twist of FATe: lipid droplets and inflammatory lipid mediators. Biochimie. 2020;169:69–87.
Article CAS PubMed Google Scholar
Gueguen E, Morsy Y, Scharl M, et al. Endothelial barrier disruption by lipid emulsions containing a high amount of N3 fatty acids (Omegaven) but not N6 fatty acids (Intralipid). Cells. 2022;11(14):2202.
Comments (0)